All In MedTech

FDA Clearance Tracker · P100029-S003

TRIFECTA HEART VALVE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 22, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 22, 2011

Approved

Time to decision

216 days

Received May 20, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100029-S003
Device name
TRIFECTA HEART VALVE
Applicant location
St. Paul, MN
Received
May 20, 2011
Decided
Dec 22, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100029

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN ADDITIONAL STERILIZATION SITE AND FOR FINAL PACKAGING OPERATIONS LOCATED AT ST. JUDE MEDICAL, PAMPULHA, BRAZIL.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.